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1. Introduction 
Differences have been reported in the composition 
[1,2] dynamics and function [3-5] of the cell surface 
membrane ofnormal and malignant cells, which differ 
also in their response to normal growth control. 
Studies with various compounds that control cell 
functions have suggested that changes in growth 
control were accompanied by a qualitative or quanti- 
tative alteration i cell-surface receptors for substances 
such as epidermal growth factor [6], insulin [7] and 
catecholamines [8,9]. The response of cells to hor- 
mones is apparently regulated, among other factors, by 
the rate of termination of the stimulus and the cells 
capability to avoid an endless response. Avoidance 
from an uncontrolled endless response isachieved in 
various cell types by desensitization r refractoriness, 
[19-22] either specifically to the inducer [10-12, 
14-19,22] or nonspecifically [13,21,22]. We have 
found that malignant leukemic ells can differ in their 
capacity to desensitize to/3-adrenergic hormones [23]. 
Differences in cell response to surface mediated 
hormones and growth regulating substances may 
reflect differences in membrane cytoskeleton i ter- 
actions. The present experiments were undertaken, to
elucidate to what extent hormonal response isdepen- 
dent on the integrity of the cytoskeleton constituents, 
microtubules and microfdaments, which have been 
shown to participate in the dynamics of cell surface 
receptors in different cell types [24-28]. Our results 
have indicated that the/3-adrenergic stimulation of 
cyclic AMP was increased by pre-treatment of the 
desensitizing MGI÷D ÷ leukemic ells and normal 
macrophages with the microtubule disrupting tom- 
pounds vinblastine sulfate or colchicine. However, 
pre-treatment with these compounds did not effect 
the/~-adrenergic stimulation of cyclic AMP in the 
non-desensitizing MGI-D- leukemic ells. The in- 
creased cyclic AMP induction produced by vinblastine 
in MGI+D ÷ cells was inhibited by cyclic GMP. The 
results also indicate, that the sensitivity or lack of 
sensitivity to microtubule disrupting compounds on 
the t~-adrenergic hormonal stimulation, was associated 
with the competence of the leukemic ells to form 
caps with concanavalin A (ConA). It is suggested that 
the cell-surface cytoskeleton plays a role in the regula- 
tion of hormonal response, and that abnormalities in 
the surface cytoskeleton i teractions may cause 
abnormalities in the response to hormones and 
possibly other surface mediated growth regulating 
activities. 
2. Materials and methods 
The clones of myeloid leukemic ells used in these 
experiments originated [29] from a spontaneous 
myeloid leukemia in an SL mouse [30] or from 
myeloid leukemias originating in X-irradiated SJL/J 
mice [31,32]. Three clones were used. MGI÷D ÷ clone 11 
was derived from the spontaneous SL myeloid 
leukemia. This clone can be induced by the macro- 
phage granulocyte inducer protein MGI [3,33] to dif- 
ferentiate to mature macrophages and granulocytes, 
including the formation of cell surface Fc and C3 
rosettes [34] Fc and C3 mediated immune phago- 
cytosis [32] and the synthesis and secretion of lyso- 
zyme [35]. MGI-D- clone 1 originated from an 
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SJL/J myeloid leukemia nd this clone was not 
inducable by MGI for any of these properties. The 
MGI÷D ÷ clone 7-M 18 was a mutant selected from a 
MGI-D- clone derived from another SJL/J myeloid 
leukemia [32]. The cells were grown as in [23,31] 
and seeded for experiments togive after 3 days a cell 
density of 1-1.5 × 106 cells/ml culture medium. 
They were then preincubated with 1 mM amino- 
phylline (Sigma Co.) at 107 cells/ml in fresh culture 
medium without serum for 30 min, with or without 
different compounds and zero time samples were 
taken. (-)Isoproterenol (Sigma Co.) was added 
(100/aM) and after the indicated intervals, cyclic 
AMP was extracted, purified by passage through a
5 × 0.5 cm Dowex-1 microcolumn as in [36] and 
assayed by the method in [37]. 
Con A cap formation was tested after preincubation 
of cells with or without 1/ag/ml vinblastine sulfate 
(Eli Lilly Co.), washing the cells in PBS and incubation 
for 15 min with 100/ag/ml f uorescent Con A (Miles- 
Yeda) [38]. 
3. Results 
Induction of cyclic AMP synthesis by the/3- 
adrenergic agonist (-)isoproterenol was determined 
in normal mouse peritoneal macrophages, MGI÷D + 
and MGI-D- leukemic ells which are induced or not 
induced, respectively, todifferentiate by the differen- 
tiation inducing protein MGI [31'32]. When tested 
after treatment with (-)isoproterenol, the level of 
cyclic AMP in MGI+D ÷ clone 11 cells, like in normal 
macrophages, decreased to the initial level within 
15 minutes, whereas the MGI-D- clone 1 cells did 
not show this rapid decrease. The level of cyclic AMP 
in clone 1 cells at 15 min after the addition of (-)iso- 
proterenol was still 60-100% higher than the basal 
level (table 1). The decrease in cyclic AMP level in 
MGI+D + clone 11 was obtained both in the presence 
or the absence of the phosphodiesterase inhibitors 
aminophylline oriso-butyl methylxanthine, suggesting 
that the decrease incyclic AMP level probably reflects 
early termination of its synthesis and not only induc- 
tion ofphosphodiesterases [23]. A second application 
of the hormone to MGI÷D + clone 11 or to normal 
macrophages in the desensitized state failed to again 
induce cyclic AMP synthesis [23]. The results in 
table 1 indicate that 1 #g/ml vinblastine does not sig- 
nificantly change the response of MGI-D- clone 1 
cells to (-)isoproterenol. However, the same treat- 
ment potentiates the induction of cyclic AMP by the 
hormone in MGI÷D + clone 11 cells with a 1.9-2.5- 
fold increase in maximal induction found at the 
peak of the hormone ffect 1-3 min after the addi- 
tion of (-)isoproterenol. Vinblastine had a similar 
effect on cyclic AMP stimulation by (-)isoproterenol 
in normal peritoneal macrophages (table 1), but this 
microtubule disrupting compound had no significant 
effect on the basallevel of cyclic AMP before hormonal 
stimulation in either of these cell types. 
In order to study if the effect of vinblastine was 
associated with the disruption of microtubules, we 
tested the effect of other compounds that effect he 
cytoskeleton on the maximal (-)isoproterenol stimula- 
tion. Colchicine showed asimilar effect o vinblastine, 
with a 2-fold increase in the effect of (-)isoproterenol 
on MGI+D ÷ clone 11 and normal macrophages, but no 
effect on MGI-D- clone 1 (fig.l). On the other hand 
cytochalasin B, which alters microfilaments, was 
inactive. Studies with normal and abnormal poly- 
morphonuclear leukocytes have shown [39] that 
cyclic GMP may promote microtubule polymeriza- 
tion. We have, therefore, tested the effect of cyclic 
GMP on the (-)isoproterenol stimulation of cyclic 
AMP. Figure 1 shows that although cyclic GMP by 
itself had no effect on the hormonal stimulation, 
cyclic GMP antagonised 80% of the vinblastine or col- 
chicine potentiation of the hormonal response in 
MGI÷D + clone 11. There was no such effect with GTP. 
Kinetic experiments (table 1) were carried out to 
determine, if disruption of microtubules ffects not 
only the maximal hormonal stimulation, but also its 
duration and desensitization to the hormone in 
MGI*D + clone 11 cells. In 3 out of 6 experiments, the 
level of cyclic AMP at 15 min after (-)isoproterenol 
stimulation i  the presence of vinblastine was 40-60% 
higher than after stimulation without vinblastine, 
whereas in the other 3 experiments here was no dif- 
ference. With MGI-D- clone 1 cells there was no such 
effect of vinblastine since these cells where not 
desensitized. 
The difference in response of ~-adrenergic receptor 
function to microtubule disrupting agents in these 
leukemic ells, was correlated with Con A cap forma- 
tion which is also regulated by cell surface microtubules. 
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Fig.1. (-)Isoproterenol stimulation of cyclic AMP in the 3 leukemic ell clones and in normal maerophages. Cells were prein- 
eubated for 30 min without or with 1 t~g]ml vinbhstine sulfate, 1ug/ml eolehicine or 0.1 mM cyclic GMP before addition of 
(-)isoproterenol. Cyclic AMP was determined before and 1 min after (-)isoproterenol addition. (6) Without; (,) with the 
addition of (-)isoproterenol. The basal level (equal to 100%) of cyclic AMP in clone 1, clone 7-M18, clone 11 and normal macro- 
phages was 1.2, 0.8, 0.75 and 0.85 pmol/106 cells, respectively. 
* Significantly higher than values of the same clone treated only with (-)isoproterenol, P > 0.005 
* Significantly ower than the same clone treated only with vinblastine, P > 0,01 
Table 2 summarizes the effects of a microtubule dis- 
rupting compound on/3-adrenergic stimulation and on 
the frequencies of Con A induced caps that are 'bound' 
or not 'bound' to microtubules [40]. For this com- 
parison, we have also included another MGI÷D ÷ clone, 
7-M18, which had only 15% Con A caps bound do 
microtubules compared to 45% cells with such caps 
in MGI÷D ÷ clone 11 (table 2). The high effect of vin- 
blastine on/3.adrenergic stimulation i  MGI÷D ÷ 
clone 11, was correlated with a high percentage of
Con A caps bound to microtubules. The MGI*D ÷ 
clone 7-M18, with only 15% Con A caps bound to 
mierotubules, was only partially responsive to the 
effect of vinblastine on/~-adrenergic stimulation 
(fig.1 and table 2). The MGI-D- clone 1 cells are 
unable to form Con A caps without vinblastine treat- 
ment and they also do not respond to microtubule 
disruption in the process of ~.adrenergie stimulation 
(table 2). 
4. Discussion 
The present study has shown that disruption of 
microtubules in normal and some leukemic white 
blood cells can potentiate/3-adrenergic stimulation of 
cyclic AMP. This extends a recent study which shows 
that disruption of microtubules in normal human 
!eukocytes potentiates cyclic AMP stimulation by 
various inducers [41 ]. However, by studying different 
types of leukemic ells, we have found that the 
inhibitory effect of intact microtubules on this 
hormonal stimulation was not universal for all cells, 
and seems to be associated with the general activity 
of cell surface microtubules. The highest effect of 
microtubule disrupting compounds on/3.adrenergic 
cyclic AMP stimulation i  MGI*D ÷ leukemic ells was 
correlated with highest percent of cells forming Con A 
caps after treatment with these same compounds. 
Treatment of MGI-D- leukemic ells with these 
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Table 2 
Microtubule association with fl-adrenergic receptor stimulation and Con A cap formation 
June 1978 
7 
Cell type and no. Functional f -aclrenergic 
receptors 
Con A cap formation 
% Microtubule % Microtubule 
'free' caps b 'bound' caps b
Leukemic, type MGFD ÷ 
Clone 11 'Bound' to microtubules a 45 ± 10 45 ± 15 
Clone 7-M18 Partially 'bound' 85 ± 15 15 ± 10 
Leukemic, type MGI- D- 
Clone 1 'Free' 3 c • 5 40 ± 15 
a 'Bound' indicates that disruption of microtubules potentiated cyclic AMP stimulation by (-)iso- 
proterenoi and 'free' indicates no effect of microtubule disruption on cyclic AMP stimulation by 
(-)isoproterenol. See details in table 1, riga and the text 
b Capping with fluorescence Con A was tested as in section 2. Microtubule 'free' caps are the percent 
of cells with a cap without reatment with vinblastine; mierotubule 'bound' caps are the % cells with 
a cap after treatment with vinblastine minus the percent of 'free' caps. Data are averages from counts 
of 300 cells]expt in 3 expts 
c Significantly ower than the values for clones 11 and 7-M18,p < 0.001 
compounds did not potentiate fl-adrenergic stimulation 
of cyclic AMP and these cells are also unable to form 
Con A caps without vinblastine or colchicine. These 
MGI -D-  cells are also defective in cap formation with 
murine leukemia virus gs antigens [42] and H-2 
histocompatabil ity antigens (Bushkin and L.S., to be 
published), suggesting that these cells have a general 
poor mobil ity of  surface receptor which could account 
also for their apparently microtubule independent 
fl-adrenergic receptors. 
From the results available in the literature and this 
and our previous tudy [23] the following hypothesis 
is proposed (fig.2). We suggest: 
1. That the coupling process [43--46] between 
cell surface hormone or neurotransmitter r cep. 
tors and the adenylate cyclase nzyme is a 
dynamic process influenced by surface cyto- 
skeleton components. 
. In the normal situation, this coupling is antago- 
nized by an uncoupling system that is also in- 
fluenced by this cytoskeleton. Assuming that 
coupling and uncoupling are each regulated by 
processes A and B, respectively, the ratio of  
A/B at different imes after hormonal stimula. 
tion will determine both the maximal hormonal 
induction and the duration of the hormonal 
response. Conditions in which B > A will mean 
a smaller induction and early termination of  the 
hormonal stimulation as a result of an efficient 
uncoupling process. Once established, this un- 
coupling process may inhibit a second stimula- 
tion for some time. 
I ,  NON-INDUCED STATE H. INDUCED. PRECOUPLED 
OUTSIDE 
INSIDE 
SENSITIZATION PROCESSE~ MT [A] ~ : 
]~.UNCOUPLED, DESENSITIZED 'm'.cOUPLED, ACTIVE STATE 
UNCOUPUNG 
PROCESSES 
,, [el 
MT 
Fig.2. Possible role of microtubules in the hormonal stimula- 
tion of membrane associated a enylate cyclase. R, receptor 
site;AC, adenylate cyclase; MT, functional microtubules; He, 
hormone; n(T), nonpolymerized tubulin molecules or non- 
functional mierotubules; [A], coupfing processes; [B], un- 
coupling processes; outside and inside indicate position in 
the membrane. 
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3. The rate of lateral movement of the surface 
receptors or the adenylate cyclase can be in- 
fluenced by surface bound contractile proteins 
and that this effects the ration A/B. 
According to this hypothesis, leukemic ells with 
low functional surface microtubules, (MGI-D-), 
will be independent of microtubules in the process of 
surface mediated hormonal stimulation, whereas in 
the normal and the MGI+D ÷ leukemic ells, a higher 
level of functional surface microtubules can explain 
the enhanced hormonal stimulation of cyclic AMP 
when the microtubules are disrupted. The observation 
that in the absence of vinblastine or colchicine the 
hormonal stimulated and the basal cyclic AMP level 
in the MGI-D- cells is 50-80% higher than in the 
MGI÷D ÷ ceils or normal macrophages, support he 
suggestion that in the MGI-D- cells the activity of 
adenylate cyclase is released from microtubule regula- 
tion, whereas in MGI+D ÷ and in normal macrophages, 
the activity of this enzyme is inhibited by intact 
microtubules. The finding that the leukemic eils 
with low functional surface microtubules (MGI-D-) 
are unable to desensitize after/~-adrenergic stimulation 
[23] and the possibly slower desensitization f 
MGI*D ÷ cells in the presence of vinblastine of col- 
chicine suggest, that alterations in the surface micro- 
tubule system in abnormal cells can result in changes 
in the capacity of cells to desensitize. It has been 
shown with normal rat ovaries, that contractile 
proteins can take part in the process of refractoriness 
to hormonal stimulation ([47] and Zor, Strelovici, 
Lamprecht, Lindner and Oplatka, to be published). 
The comparison of normal with different types of 
malignant cells used in this study, indicate that 
hormonal response and changes in its regulation i  
some abnormal cells may reflect abnormal functions 
of surface-associated contractile proteins. This may 
alter both the maximal hormonal response and its 
duration. 
Fluctuations in the response of cells to hormones 
and other surface.mediated growth promoting agents 
during the cell cycle, may also be due to fluctuations 
in functional surface-associated contractile proteins. 
In support of this, we have previously shown that 
microtubule disrupting agents can influence adif- 
ferential cytotoxic effect on multiplying and non- 
multiplying fibroblasts and neuroblastoma ceils [48] 
and it has also been found that the arrangements of 
contractile proteins can fluctuate during the cell cycle 
[49,50]. 
In vitro experiments have indicated the role of 
GTP and divalent ions on microtubule assembly [51]. 
It has been suggested that cyclic GMP promotes 
microtubule assembly in polymorphonuclear leuko- 
cytes [39] and this cyclic nucleotide is also regulated 
during the cell cycle [52]. In the present study we 
were able to inhibit the effect of vinblastine or col- 
chicine on hormonal stimulation by adding cyclic 
GTP before the hormone. Since the present and 
previous tudy [23] indicate differences in the 
regulation of cyclic AMP between different leukemic 
cell types, one can suggest hat differences in the 
regulation of cyclic GMP may reflect changes in the 
assembly or function of rnicrotubules in these ceils. 
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